Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
NCT07052162Phase 4Recruiting
- Sponsor
- Curtin University
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafenoquine in vivax malaria, sponsored by Curtin University. Started Oct 2025; status: recruiting.
02
Drugs
tafenoquine
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT07052162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07052162.